Spinal and Bulbar Muscular Atrophy Latest Advances

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 10, 2025

A case of spinal and bulbar muscular atrophy with acute bilateral vocal cord paralysis suddenly apparent after infection

Journal: Rinsho shinkeigaku = Clinical neurology

Published: September 28, 2025

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: September 22, 2025

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

Journal: European review for medical and pharmacological sciences

Published: September 04, 2025

Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease

Journal: Zhonghua nei ke za zhi

Published: September 04, 2025

Peripherally administered androgen receptor-targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model.

Journal: The Journal of clinical investigation

Published: August 28, 2025

Spinal and bulbar muscular atrophy with hand tremors and chronic limb weakness, Kennedy disease.

Journal: BMJ case reports

Published: August 04, 2025

DCTN1-associated neurological disorder with symptoms similar to spinal bulbar muscular atrophy.

Journal: Journal of neuromuscular diseases

Published: July 16, 2025

Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets.

Journal: International journal of molecular sciences

Published: June 09, 2025

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 04, 2025

Differentiating upper- and lower motor neuron diseases using automated acoustic analysis.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: June 01, 2025

The Insufficient Number of Informative SNPs in a Preclinical Karyomapping Test for PGT-M Depends on the Reference Selected.

Journal: Journal of personalized medicine

Published: May 21, 2025

Filters

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.

A case of spinal and bulbar muscular atrophy with acute bilateral vocal cord paralysis suddenly apparent after infection

A case of spinal and bulbar muscular atrophy with acute bilateral vocal cord paralysis suddenly apparent after infection

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease

Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease

Peripherally administered androgen receptor-targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model.

Peripherally administered androgen receptor-targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model.

Spinal and bulbar muscular atrophy with hand tremors and chronic limb weakness, Kennedy disease.

Spinal and bulbar muscular atrophy with hand tremors and chronic limb weakness, Kennedy disease.

DCTN1-associated neurological disorder with symptoms similar to spinal bulbar muscular atrophy.

DCTN1-associated neurological disorder with symptoms similar to spinal bulbar muscular atrophy.

Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets.

Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets.

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.

Differentiating upper- and lower motor neuron diseases using automated acoustic analysis.

Differentiating upper- and lower motor neuron diseases using automated acoustic analysis.

The Insufficient Number of Informative SNPs in a Preclinical Karyomapping Test for PGT-M Depends on the Reference Selected.

The Insufficient Number of Informative SNPs in a Preclinical Karyomapping Test for PGT-M Depends on the Reference Selected.